Jonathan Hare

574 total citations
30 papers, 321 citations indexed

About

Jonathan Hare is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Jonathan Hare has authored 30 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 12 papers in Infectious Diseases and 11 papers in Molecular Biology. Recurrent topics in Jonathan Hare's work include HIV Research and Treatment (13 papers), vaccines and immunoinformatics approaches (8 papers) and HIV/AIDS drug development and treatment (6 papers). Jonathan Hare is often cited by papers focused on HIV Research and Treatment (13 papers), vaccines and immunoinformatics approaches (8 papers) and HIV/AIDS drug development and treatment (6 papers). Jonathan Hare collaborates with scholars based in United States, United Kingdom and Uganda. Jonathan Hare's co-authors include Rachel Rosenthal, Nnennaya Kanu, Sergio A. Quezada, Subramanian Venkatesan, Nicholas McGranahan, Jiří Bártek, Reuben S. Harris, Charles Swanton, Jill Gilmour and Philip R. Johnson and has published in prestigious journals such as PLoS ONE, Annals of Oncology and Science Translational Medicine.

In The Last Decade

Jonathan Hare

28 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Hare United States	7	143	102	77	75	64	30	321
Miles Smith United States	10	152 1.1×	118 1.2×	86 1.1×	125 1.7×	33 0.5×	16	377
Anastasia Latanova Russia	8	128 0.9×	49 0.5×	66 0.9×	87 1.2×	44 0.7×	22	290
P. Chikoti United Kingdom	6	133 0.9×	129 1.3×	56 0.7×	224 3.0×	114 1.8×	8	370
Kazuhiro Matsuoka Japan	14	228 1.6×	150 1.5×	189 2.5×	100 1.3×	31 0.5×	28	483
Pedro A. Lamothe United States	10	198 1.4×	89 0.9×	135 1.8×	262 3.5×	42 0.7×	18	584
Benedikt Asbach Germany	11	190 1.3×	37 0.4×	132 1.7×	75 1.0×	52 0.8×	28	373
Marie Lambelé United States	10	136 1.0×	231 2.3×	107 1.4×	137 1.8×	21 0.3×	11	425
Kimberly A. Kraynyak United States	14	132 0.9×	40 0.4×	56 0.7×	212 2.8×	98 1.5×	28	413
Athina Kilpeläinen Spain	10	116 0.8×	47 0.5×	88 1.1×	130 1.7×	42 0.7×	19	290
Emma L. Reuschel United States	12	129 0.9×	40 0.4×	166 2.2×	193 2.6×	44 0.7×	17	465

Countries citing papers authored by Jonathan Hare

Since Specialization

Citations

This map shows the geographic impact of Jonathan Hare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Hare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Hare more than expected).

Fields of papers citing papers by Jonathan Hare

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Hare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Hare. The network helps show where Jonathan Hare may publish in the future.

Co-authorship network of co-authors of Jonathan Hare

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Hare. A scholar is included among the top collaborators of Jonathan Hare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Hare. Jonathan Hare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hare, Jonathan, et al.. (2024). Sustainable integration of artificial intelligence and machine learning approaches within the African infectious disease vaccine research and development ecosystem. Frontiers in Pharmacology. 15. 1499079–1499079. 1 indexed citations

Andisi, Cheryl, Jonathan Hare, Joakim Esbjörnsson, et al.. (2024). Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya. Frontiers in Immunology. 14. 1283559–1283559. 1 indexed citations

Adambekov, Shalkar, et al.. (2023). Understanding COVID-19 vaccine hesitancy in health care professionals in Central and West Asia: lessons for future emergency mass vaccination campaigns. Frontiers in Public Health. 11. 1196289–1196289. 3 indexed citations

Araña, Allyson A., Jonathan Hare, Joseph K. Maddry, et al.. (2023). Utilization of the En Route Aeromedical Patient Movement Form by Critical Care Air Transport Teams. Military Medicine. 188(Supplement_6). 436–443. 1 indexed citations

Kapaata, Anne, Sheila N. Balinda, Jonathan Hare, et al.. (2022). Infection with HIV-1 subtype D among acutely infected Ugandans is associated with higher median concentration of cytokines compared to subtype A. IJID Regions. 3. 89–95. 3 indexed citations

Fernández, Natalia, Peter Hayes, Julia Makinde, et al.. (2022). Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay. Frontiers in Immunology. 13. 1029029–1029029. 1 indexed citations

Marancik, Katrin E., et al.. (2021). Cross-shelf and seasonal variation in larval fish assemblages on the southeast United States continental shelf off the coast of Georgia. AquaDocs (United Nations Educational, Scientific and Cultural Organization). 1 indexed citations

Hayes, Peter, Natalia Fernández, Christina Ochsenbauer, et al.. (2021). Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set. PLoS ONE. 16(11). e0260118–e0260118. 4 indexed citations

Makinde, Julia, Eunice Nduati, Anna Freni Sterrantino, et al.. (2021). A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 Infection. Frontiers in Immunology. 12. 634832–634832. 4 indexed citations

10.

Umviligihozo, Gisele, Erick M. O. Muok, Rui Xu, et al.. (2021). Increased Frequency of Inter-Subtype HIV-1 Recombinants Identified by Near Full-Length Virus Sequencing in Rwandan Acute Transmission Cohorts. Frontiers in Microbiology. 12. 734929–734929. 4 indexed citations

11.

Hare, Jonathan, David Morrison, & Morten Nielsen. (2021). Sampling SARS-CoV-2 Proteomes for Predicted CD8 T-Cell Epitopes as a Tool for Understanding Immunogenic Breadth and Rational Vaccine Design. Frontiers in Bioinformatics. 1. 622992–622992. 6 indexed citations

12.

Gounder, Kamini, Tarylee Reddy, Marcel Tongo, et al.. (2021). Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa. Retrovirology. 18(1). 11–11. 3 indexed citations

13.

Seaton, Kelly E., Sheetal Sawant, Jonathan Hare, et al.. (2021). Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS. Frontiers in Immunology. 12. 709994–709994. 6 indexed citations

14.

Rosenthal, Rachel, Andrew Fioré-Gartland, Sheila N. Balinda, et al.. (2021). Utilizing Computational Machine Learning Tools to Understand Immunogenic Breadth in the Context of a CD8 T-Cell Mediated HIV Response. Frontiers in Immunology. 12. 609884–609884. 10 indexed citations

15.

Priddy, Frances, David Lewis, Huub C. Gelderblom, et al.. (2019). A003 Protocol - A Phase 1, randomized, blinded, dose-escalation study of rAAV1-PG9DP recombinant AAV vector coding for PG9 antibody in healthy male adults. Figshare.

16.

Priddy, Frances, David Lewis, Hans Gelderblom, et al.. (2019). Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial. The Lancet HIV. 6(4). e230–e239. 105 indexed citations

17.

Pasloske, Kirby, Millagahamada G. Ranasinghe, Susanne K. Sauer, & Jonathan Hare. (2018). The bioequivalence of a single intravenous administration of the anesthetic alfaxalone in cyclodextrin versus alfaxalone in cyclodextrin plus preservatives in cats. Journal of Veterinary Pharmacology and Therapeutics. 41(3). 437–446. 6 indexed citations

18.

Venkatesan, Subramanian, Rachel Rosenthal, Nnennaya Kanu, et al.. (2018). Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution. Annals of Oncology. 29(3). 563–572. 104 indexed citations

19.

Engelen, Marc, et al.. (2010). Effectiveness of an otic product containing miconazole, polymyxin B and prednisolone in the treatment of canine otitis externa: multi-site field trial in the US and Canada.. 8(1). 21–30. 12 indexed citations

20.

Conboy, Gary, et al.. (2009). Efficacy of a Single Topical Application of Advantage Multi® (= Advocate®) Topical Solution (10% Imidocloprid + 2.5% Moxidectin) in the Treatment of Dogs Experimentally Infected with Crenosoma vulpis. Parasitology Research. 105(S1). 49–54. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact